Cytokine Balance in Major Depression and Sertraline Therapy
Author Information
Author(s): Levent Sutcigil, Cagatay Oktenli, Ugur Musabak, Ali Bozkurt, Adnan Cansever, Ozcan Uzun, S. Yavuz Sanisoglu, Zeki Yesilova, Nahit Ozmenler, Aytekin Ozsahin, Ali Sengul
Primary Institution: Gülhane Military Medical Academy
Hypothesis
What is the role of specific cytokines in major depression and how does sertraline therapy affect these levels?
Conclusion
The study found that sertraline therapy can correct some cytokine imbalances in patients with major depression.
Supporting Evidence
- Proinflammatory cytokines were significantly higher in depressed patients compared to healthy controls.
- Anti-inflammatory cytokines were significantly lower in depressed patients compared to healthy controls.
- Sertraline treatment decreased levels of proinflammatory cytokines and increased levels of anti-inflammatory cytokines.
- The response rate to sertraline treatment was 77% among the patients.
- Changes in cytokine levels correlated with changes in depression severity as measured by the Hamilton Depression Rating Scale.
Takeaway
People with major depression have different levels of certain chemicals in their body that can affect their mood, and taking a medicine called sertraline can help balance these chemicals.
Methodology
The study measured cytokine levels in 23 patients with major depression before and after 8 weeks of sertraline treatment.
Potential Biases
Relying on clinician diagnosis rather than structured interviews may introduce bias.
Limitations
The sample size was small, and the study design was simple, which may limit the generalizability of the findings.
Participant Demographics
23 patients (11 females, 12 males) with first episode unipolar depression and 25 healthy controls (12 females, 13 males).
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website